The next wave of psychedelics focuses on brain rewiring without the trip By separating therapeutic neuroplasticity from hallucinations, new psychedelic-inspired molecules could make treatment safer and more accessible. Written byBree Foster, PhD

The next wave of psychedelics focuses on brain rewiring without the trip By separating therapeutic neuroplasticity from hallucinations, new psychedelic-inspired molecules could make treatment safer and more accessible. Written byBree Foster, PhD https://www.drugdiscoverynews.com/the-next-wave-of-psychedelics-focuses-on-brain-rewiring-without-the-trip-17014?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-9HP-ynVJEZyhGqtQb8Ui3rE7Pkyw-qDybouSCAvOeLqtGKWCpcPfVMscfYj9WmM2i_z-KX68x7b6R0zuoEq1bzv0P0ZQ&_hsmi=436086801&utm_content=436086801&utm_source=hs_email For decades, psychedelics like psilocybin and N,N-dimethyltryptamine (DMT) have intrigued scientists and clinicians with their ability to rapidly reshape the brain and improve mental health. Clinical trials have shown promise for conditions ranging from depression and anxiety to post-traumatic stress disorder (PTSD), but there is still a potential downside.